Evaluation of a new five-injection, two-site, intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India

Current Therapeutic Research - Clinical and Experimental

Volumn 66, Issue 4, 2005, Pages 323-334

  Sudarshan, M K ^a   Madhusudana, S N ^b   Mahendra, B J ^a   Ashwath Narayana, D H ^a   Ananda Giri, M S ^a   Popova, O ^c   Vakil, H B ^d  

^a KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^c Clin Research and Medical Affairs   (Italy)

^d Chiron Vaccines   (India)

Author keywords

Intradermal rabies vaccination; KIMS ID regimen; Rabies; Randomized controlled trial

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG TOLERABILITY; FEMALE; FLUORESCENCE; FOLLOW UP; HUMAN; IMMUNOGENICITY; INDIA; INJECTION PAIN; INJECTION SITE; INJECTION SITE REACTION; MALE; PHYSICIAN; PRIORITY JOURNAL; RABIES; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 26444531017     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2005.08.009     Document Type: Article

References (23)

1. Publication no. WHO/CDS/CSR/APH/99.4. Available at: World Health Organization, and Department of Communicable Disease Surveillance and Response World Survey for Rabies No. 33 for the year 1997 [WHO Web site] Accessed June 1, 2005 1999 WHO Geneva, Switzerland
2. Association for the Prevention and Control of Rabies in India. Assessing the burden of rabies in India: A national multicentric survey. Progress Report. 2003. Available at: www.vet.ed.ac.uk. Accessed June 1, 2005.
3. (Suppl) Bhalla S., and Nagar S. Analysis of complications of nervous tissue anti-rabies vaccines in Jamnagar, Gujarat Ind J Int Med. 11 2001 13 16
4. Singh S., and Kumar T. Rabies vaccines-An overview J APCRI. 1 1999 14 20
5. 7th report [CDC Web site] World Health Organization Accessed June 1, 2005 Expert Committee on Rabies 1984 WHO Geneva, Switzerland Accessed June 1, 2005 Accessed June 1, 2005
6. Rabies prevention-United States, 1984 MMWR Morb Mortal Wkly Rep. 33 1984 393 402
7. Rabies prevention-United States, 1984 MMWR Morb Mortal Wkly Rep. 33 1984 407 408
8. 8th report [CDC Web site] World Health Organization Accessed June 1, 2005 Expert Committee on Rabies Technical Report Series 824 1992 WHO Geneva, Switzerland Accessed June 1, 2005 Accessed June 1, 2005
9. Chutivongse S., Wilde H., and Supich C. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination Lancet. 335 1990 896 898
10. Briggs D.J., Banzhoff A., and Nicolay U. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine Bull World Health Organ. 78 2000 693 698
11. Madhusudana S.N., Anand N.P., and Shamsundar R. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for postexposure prophylaxis for rabies Natl Med J lndia. 14 2001 145 147
12. Jaiiaroensup W., Lang J., and Thipkong P. Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally (Results of a prospective randomized trial) Vaccine 16 1998 1559 1562
13. Association for Prevention and Control of Rabies in India. In: Proceedings of the National Seminar on Intradermal Rabies Vaccination. February 25, 2003; Bangalore, India.
14. Khawplod P., Tantawichien T., and Wilde H. Use of rabies vaccines after reconstitution and storage Clin Infect Dis. 34 2002 404 406
15. Available at: World Health Organization Accessed June 1, 2005 WHO Expert Consultation on Rabies Technical Report Series 931 [WHO Web site] 2004 WHO Geneva, Switzerland
16. Available at: European Agency for the Evaluation of Medicinal Products Accessed June 1, 2005 International Conference on Harmonisation-World Health Organization Guideline for Good Clinical Practice [EMEA Web site]. ICH Topic E6 2002 WHO Geneva, Switzerland
17. Smith J.S., Yager P.A., and Baer G.M. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus neutralizing antibody Meslin F.-X. Kaplan M.M. Koprowsky H. Laboratory Techniques in Rabies 4th ed. 1996 World Health Organization Geneva, Switzerland 181 192
18. Madhusudana S.N., Sanjay T.V., Mahendra B.J., and Suja M.S. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen Int JInfect Dis. 8 2004 175 179
19. Publication no. WHO/EMC/Z00 96.6. Available at: World Health Organization Accessed August 1, 2005 Department of Communicable Disease Surveillance and Response WHO Recommendations on Rabies Post-Exposure Treatment and the Correct Technique of Intradermal Immunization Against Rabies [WHO Web site] 1988 WHO Geneva, Switzerland
20. Sabchareon A., Chantavanich P., and Pasuralertsakul S. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations withpurified Vero cell rabies vaccine Pediatr Infect Dis J 17 1998 1001 1007
21. Yang Y., and Zhang J. An experimental study on the endurance of immunologic memory of intradermal micro-injection with rabies vaccine and boosting immune effect J Epidemiol. 9 1999 209 215
22. Beran J., Honegr K., Banzhoff A., and Malerczyk C. Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: Investigation of the immunogenicity ofserially diluted purified chick embryo cell rabies vaccine Vaccine 23 2005 3902 3907
23. Sudarshan M.K., Mahendra B.J., and Ashwath Narayana D.H. A cost accounting analysis of production of Semple (sheep brain) vaccine in India Journal of Association for Prevention and Control of Rabies in India 4 2002 40 41